Corvus Pharmaceuticals (CRVS US)

Corvus Pharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical company. The Company focuses on the development of novel and first-in-class agents that target the immune system to treat patients with cancer. Corvus Pharmaceuticals offers its services in the United States.